JP2012528865A5 - - Google Patents

Download PDF

Info

Publication number
JP2012528865A5
JP2012528865A5 JP2012514033A JP2012514033A JP2012528865A5 JP 2012528865 A5 JP2012528865 A5 JP 2012528865A5 JP 2012514033 A JP2012514033 A JP 2012514033A JP 2012514033 A JP2012514033 A JP 2012514033A JP 2012528865 A5 JP2012528865 A5 JP 2012528865A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
con
halo
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012514033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012528865A (ja
JP5850459B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/036832 external-priority patent/WO2010141424A1/en
Publication of JP2012528865A publication Critical patent/JP2012528865A/ja
Publication of JP2012528865A5 publication Critical patent/JP2012528865A5/ja
Application granted granted Critical
Publication of JP5850459B2 publication Critical patent/JP5850459B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012514033A 2009-06-02 2010-06-01 11βヒドロキシステロイドデヒドロゲナーゼ1のカルバマート及びウレアインヒビター Expired - Fee Related JP5850459B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21759309P 2009-06-02 2009-06-02
US61/217,593 2009-06-02
US26940609P 2009-06-24 2009-06-24
US61/269,406 2009-06-24
PCT/US2010/036832 WO2010141424A1 (en) 2009-06-02 2010-06-01 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1

Publications (3)

Publication Number Publication Date
JP2012528865A JP2012528865A (ja) 2012-11-15
JP2012528865A5 true JP2012528865A5 (enExample) 2013-07-18
JP5850459B2 JP5850459B2 (ja) 2016-02-03

Family

ID=42315408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012514033A Expired - Fee Related JP5850459B2 (ja) 2009-06-02 2010-06-01 11βヒドロキシステロイドデヒドロゲナーゼ1のカルバマート及びウレアインヒビター

Country Status (6)

Country Link
US (1) US9163012B2 (enExample)
EP (1) EP2438043A1 (enExample)
JP (1) JP5850459B2 (enExample)
AR (1) AR076936A1 (enExample)
TW (1) TW201103910A (enExample)
WO (1) WO2010141424A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8575156B2 (en) 2007-07-26 2013-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja) 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状カルバゼート及びセミカルバジドインヒビター
US8598160B2 (en) 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
NZ588954A (en) 2008-05-01 2012-08-31 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CN104327062A (zh) 2008-07-25 2015-02-04 贝林格尔·英格海姆国际有限公司 11β-羟基类固醇脱氢酶1的环状抑制剂
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2729993A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
EP2393807B1 (en) 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
AR076936A1 (es) 2009-06-02 2011-07-20 Vitae Pharmaceuticals Inc Inhibidores de carbamato y urea de la 11 beta hidroxiesteroide deshidrogenasa 1
ES2350077B1 (es) 2009-06-04 2011-11-04 Laboratorios Salvat, S.A. Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1.
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
EP2496589B1 (en) 2009-11-05 2014-03-05 Boehringer Ingelheim International GmbH Novel chiral phosphorus ligands
WO2011149822A1 (en) 2010-05-26 2011-12-01 Boehringer Ingelheim International Gmbh 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
CA2806655A1 (en) 2010-07-28 2012-02-02 Bayer Intellectual Property Gmbh Substituted imidazo[1,2-b]pyridazines
EA201300522A1 (ru) 2010-11-02 2013-11-29 Бёрингер Ингельхайм Интернациональ Гмбх Фармацевтические комбинации для лечения метаболических нарушений
DK2694510T3 (en) 2011-04-07 2016-01-18 Bayer Ip Gmbh IMIDAZOPYRIDAZINER AS AKT kinase inhibitors
EP2996692B1 (en) 2013-05-14 2021-06-30 Medizinische Hochschule Hannover Means and methods for treating cancer
EP3235813A1 (en) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Aza-tetra-cyclo derivatives
CN115340481B (zh) * 2022-08-08 2025-12-12 广州谷森制药有限公司 一种采用固载镍催化工业化生产氘代医药中间体的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270302A (en) 1988-12-21 1993-12-14 Abbott Laboratories Derivatives of tetrapeptides as CCK agonists
US5912114A (en) 1997-09-12 1999-06-15 Johnson & Johnson Medical, Inc. Wound diagnosis by quantitating cortisol in wound fluids
TWI221102B (en) 2002-08-30 2004-09-21 Sumitomo Heavy Industries Laser material processing method and processing device
AU2003300902A1 (en) * 2002-12-13 2004-07-09 Smithkline Beecham Corporation Piperidine derivatives as CCR5 antagonists
WO2004101562A2 (en) * 2003-05-13 2004-11-25 Schering Corporation Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
WO2008001817A1 (fr) * 2006-06-27 2008-01-03 Asahi Glass Company, Limited composition À CRISTAUX LIQUIDES, élément optique à cristaux liquides, et procédé de fabrication d'ÉLÉMENT OPTIQUE À CRISTAUX LIQUIDES
WO2008024497A2 (en) 2006-08-25 2008-02-28 Vitae Pharmaceuticals, Inc. INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
EP2172453A4 (en) * 2007-06-27 2010-12-22 Taisho Pharmaceutical Co Ltd CONNECTION WITH 11-β-HSD1 INHIBITING ACTIVITY
WO2009020140A1 (ja) * 2007-08-06 2009-02-12 Dainippon Sumitomo Pharma Co., Ltd. アダマンチルウレア誘導体
WO2009052319A1 (en) * 2007-10-16 2009-04-23 Northeastern University Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity
TW200944526A (en) * 2008-04-22 2009-11-01 Vitae Pharmaceuticals Inc Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
AR076936A1 (es) 2009-06-02 2011-07-20 Vitae Pharmaceuticals Inc Inhibidores de carbamato y urea de la 11 beta hidroxiesteroide deshidrogenasa 1

Similar Documents

Publication Publication Date Title
JP2012528865A5 (enExample)
JP2011518218A5 (enExample)
JP2013505946A5 (enExample)
JP2012092103A5 (enExample)
JP2019518766A5 (enExample)
JP2012515776A5 (enExample)
JP2016516043A5 (enExample)
JP2016506960A5 (enExample)
JP2017526677A5 (enExample)
JP2016503793A5 (enExample)
JP2013505945A5 (enExample)
JP2015508092A5 (enExample)
JP2017509586A5 (enExample)
JP2013504593A5 (enExample)
JP2014051526A5 (enExample)
JP2013542261A5 (enExample)
JP2013537203A5 (enExample)
JP2008535903A5 (enExample)
JP2016506961A5 (enExample)
JP2016503799A5 (enExample)
JP2014500861A5 (enExample)
JP2012513416A5 (enExample)
JP2016513696A5 (enExample)
JP2013532130A5 (enExample)
JP2017511321A5 (enExample)